University of Queensland

University of Queensland
#Advanced Research Projects Agency for Health (ARPA-H) #mRNA #RNA #University of Queensland

UQ selected by US government to develop RNA medicines

A United States Government agency has selected University of Queensland researchers to develop technology for personalised RNA medicines to be produced in hospitals, allowing lifesaving treatments to reach patients within days. UQ’s BASE mRNA Facility is part of a consortium of companies, universities and research institutes with potential… Read More

#News

Neurons
#Alzheimer's #Neuroscience #Parkinson's disease #University of Queensland

UQ technology opens new front in Alzheimer’s and Parkinson’s

A technology developed at The University of Queensland allowing scientists to observe how disease-related proteins behave inside living neurons will be used to advance early drug discovery for neurodegenerative diseases.  The Nanoscale Spatiotemporal Indexing Clustering (NASTIC) platform, spun out into Brisbane-based startup Accretion Bio, enables researchers to… Read More

#News

Genetics researcher
#Australia #Gene editing #Genetics / genomics #University of Queensland

UQ researchers drive the fight against genetic diseases

University of Queensland (UQ) scientists will accelerate research into cures for life-threatening genetic diseases from a Brisbane-based node of the new Medical Research Council Centre of Research Excellence for Mitochondrial Genome Therapeutics. Associate Professor Seth Cheetham from UQ’s Australian Institute for Bioengineering and Nanotechnology and Chief Investigator of… Read More

#News

Testing antiviral vaccines in the lab
#Antivirals #Covid-19 treatment #Ebola virus #Infectious diseases #Pneumonia #University of Queensland #Viral infections #Virus treatment

The lightbulb moment behind a potential antiviral breakthrough 

An unexpected observation by a University of Queensland (UQ) researcher could lead to a new treatment for deadly infectious diseases including Covid‑19, pneumonia in infants and children, or viral infections caused by Ebola and hantavirus.   UQ’s Australian Institute for Bioengineering and Nanotechnology neuroscientist and biochemist Dr… Read More

#News

Demyelination of neuron
#MND #Neurodegenerative disorders #Neuroscience #University of Queensland

New drug could be a ‘breakthrough’ for MND

University of Queensland researchers have developed a drug that activates a hard-to-target immune receptor — a breakthrough that researchers say could lead to new treatments for neurodegenerative conditions like Motor Neurone Disease (MND). In an international collaboration with the Indian Institute of Technology, The University of Tokyo and… Read More

#Editor's Choice #News

#Blood cancer #Breast cancer #CAR T-cell therapy #Clinical trial #epilepsy #Gene mutation #Gene therapy #Genetic profiling #HER2 #Japan #Lung cancer #Nuclear medicine #Theranostics #University College London #University of Oxford #University of Queensland

This week in Drug Discovery (29 June – 3 July) 

News round-up for 29 June – 3 July by Bruno Quinney, Content Team at DDW.  This week, experts warn patients are being denied access to personalised cancer care. Cancer research is a theme elsewhere, with findings emerging from studies into a CAR T-cell therapy, lung cancer and breast cancer.  The… Read More

#News

Patients receiving chemotherapy
#Nuclear medicine #Theranostics #University of Queensland

Patients denied personalised cancer care, study says 

Cancer patients are being denied access to a “game changer” method of treatment, a new study warns.  Health economists Dr Yufan Wang and Professor Haitham Tuffaha led a review into the value of theranostic nuclear medicine, an innovative frontier in cancer treatment, and concluded patients are being… Read More

#Cancer Research #News

#Ascendis Pharma #BioIndustry Association #Cancer therapy #CHMP #Clinical trial #Diversity #European Medicines Agency #FDA #Gene therapy #Oncology #Paediatrics #Rare disease #uniQure #University of Queensland #Women in STEM

DDW Highlights: 10 March 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, figures showed the number of women in biotech leadership has stalled. Elsewhere, could… Read More

#Podcasts

Professor Glenn King working in the lab with a funnel web spider. Credit The University of Queensland
#Australia #Heart attack #Stroke #University of Queensland

Spider venom peptide trialled as cardiovascular treatment 

A potential treatment for heart attack and stroke derived from spider venom has been administered to the first participants in clinical trial.  A team of researchers from the University of Queensland, Australia published preclinical analysis showing the protein Hi1a could treat heart attack and stroke patients. The… Read More

#News

#Immunology / Virology & Vaccines #Moderna #mRNA-based vaccines #Streptococcus #University of Queensland

Researchers step closer to a universal Strep-A mRNA vaccine

A team of microbiologists and immunologists has completed the first steps towards developing a universal vaccine against Group A Streptococcus (Strep-A).  The University of Queensland-led research in partnership with Moderna and published in Nature Communications has shown Strep-A can be successfully targeted using… Read More

#Editor's Choice #News

Ultrasonic microfluidic device
#Drug discovery #Microfluidics #Regenerative Medicine #University of Queensland

‘Smart’ microgel droplets support regenerative medicine research

Australian researchers have patented a new microfluidics tool that produces ‘smart’ microgel droplets for exploring regenerative medicines.  The platform was created by Dr Ruirui Qiao and her team at UQ’s Australian Institute for Bioengineering and Nanotechnology (AIBN).  Dr Qiao said her team’s UQ-Surf microfludics platform… Read More

#News

Neurones in the brain
#Neuroscience #Parkinson's #University of Queensland

Breakthrough could boost quality of life for people with Parkinson’s disease

University of Queensland researchers have found that Gherlin, the natural ‘hunger hormone’, could be the key to preventing debilitating chronic constipation experienced by people living with Parkinson’s disease. Associate Professor Sebastian Furness from the UQ School of Biomedical Sciences said the team discovered the body’s receptor for Ghrelin had a… Read More

#News

Cancer research in laboratory
#Investment #Oncology #Prostate cancer #University of Queensland

$1.25 million support for advanced prostate cancer drug

A $1.25 million investment is driving the development of a new treatment for advanced and therapy-resistant prostate cancer at The University of Queensland.  Based on research by Professor Greg Monteith from UQ’s School of Pharmacy and Pharmaceutical Sciences, the drug (QED-203) is being developed by the Queensland… Read More

#Cancer Research #Editor's Choice #News

Woman tests blood glucose level
#Diabetes #Immunotherapy #Type 1 diabetes #University of Queensland

Pioneering clinical trial of immunotherapy for type 1 diabetes

Researchers at The University of Queensland (UQ) have launched the first clinical trial of a potentially revolutionary immunotherapy drug to treat type 1 diabetes.  Professor Ranjeny Thomas from UQ’s Frazer Institute has led the development of a targeted immunotherapy drug, ASITI-201, which has been designed to rebalance… Read More

#News #Trending News

Preparing Covid-19 vaccine for injection
#Immunology / Virology & Vaccines #Pandemic response #University of Queensland #Vaccine candidate #virus

Queensland researchers attempt 150-day vaccine challenge

Queensland researchers are attempting to create a vaccine in just 150 days to prove how far their response capabilities to a viral pandemic have come since Covid-19.  The clock started on 10 February 2025 for The University of Queensland’s Vaccine Rapid Response Team, which has been tasked… Read More

#News #Trending News